股票行情快报：创业慧康（300451）2月10日主力资金净卖出1271.58万元

Core Viewpoint - The financial performance of Chuangyue Huikang (300451) shows significant declines in revenue and net profit for the first three quarters of 2025, indicating potential challenges in its business operations and market position [2]. Financial Performance - For the first three quarters of 2025, the company's main revenue was 862 million yuan, a year-on-year decrease of 26.26% [2]. - The net profit attributable to shareholders was -122 million yuan, reflecting a year-on-year decline of 331.69% [2]. - The net profit excluding non-recurring items was -142 million yuan, down 382.12% year-on-year [2]. - In Q3 2025, the single-quarter main revenue was 285 million yuan, a decrease of 35.5% compared to the same quarter last year [2]. - The single-quarter net profit attributable to shareholders was -41.67 million yuan, down 264.2% year-on-year [2]. - The single-quarter net profit excluding non-recurring items was -47.40 million yuan, a decline of 288.66% year-on-year [2]. - The company's debt ratio stood at 20.27%, with investment income of 4.44 million yuan and financial expenses of -5.32 million yuan [2]. - The gross profit margin was reported at 49.87% [2]. Business Operations - Chuangyue Huikang's main business has shifted from primarily product development and sales to a broader focus on system construction, services, and operations [2]. - The company's offerings now include smart healthcare, internet medical services, medical IoT, health big data, smart health cities, and innovative solutions for system construction and operation services [2].